Elevated sympathetic nerve activity in patients with accelerated essential hypertension

Area of Science:

• Cardiovascular Physiology
• Hypertension Research
• Neuroendocrinology

Background:

• Accelerated hypertension is a severe form of high blood pressure.
• The role of the sympathetic nervous system in accelerated hypertension requires further elucidation.
• The interplay between the renin-angiotensin system and sympathetic activity in this condition is not fully understood.

Purpose of the Study:

• To investigate abnormalities in the sympathetic nervous system in patients with accelerated hypertension.
• To examine the relationship between the renin-angiotensin axis and sympathetic nervous system activity.
• To assess the effects of captopril, an angiotensin-converting enzyme inhibitor, on sympathetic tone.

Main Methods:

• Microneurography was used to record muscle sympathetic nerve activity (MSNA).
• Measurements were taken in patients with benign essential hypertension and accelerated essential hypertension.
• MSNA and hormonal levels (renin, angiotensin II) were assessed before and after captopril administration.

Main Results:

• Accelerated hypertensives exhibited higher basal MSNA, plasma renin activity, and plasma angiotensin II levels.
• Captopril treatment lowered arterial pressure and plasma angiotensin II in both groups, with a greater effect in accelerated hypertensives.
• MSNA significantly decreased in accelerated hypertensives after captopril but remained unchanged in benign hypertensives.

Conclusions:

• Sympathetic tone is elevated in accelerated hypertension.
• This elevated sympathetic tone is closely associated with an activated renin-angiotensin axis.
• Targeting the renin-angiotensin system may help manage sympathetic overactivity in accelerated hypertension.